this will whoosh imugene

Imugene has produced a vaccine
candidate for a major pig respiratory
disease using a gene provided and
owned by Merial. The commercial
vaccine candidate is currently being
trialed in Europe to determine its
effectiveness. Trial results to date have
been very promising. The disease causes
massive losses to pig producers globally
and there is currently no commercial
vaccine available. The market opportunity
for an effective vaccine is enormous given
the lack of competitors and Imugene is
working to develop this product aiming to
be first to market.